Dendritic cells (DCs) are antigen-presenting cells (APCs) capable of capturing haptens and to process and present them to T lymphocytes. In order to sensitize T cells for contact hypersensitivity (CHS), skin DCs suffer a maturation process with modifications on their surface molecules. The aim of this work was to evaluate changes induced by two contact sensitizers, 2,4-dinitrofluorobenzene (DNFB) and nickel sulfate (NiSO 4 ), and a non-sensitizer 2,4-dichloronitrobenzene (DCNB), on the protein levels of two activation markers, CD40 and IL-12 receptor (IL-12R), in a mouse skin dendritic cell line (FSDC). The expression of CD40 and IL-12R proteins was evaluated by western blot assay and direct immunofluorescence microscopy. The results showed that CD40 and IL-12R expression increased significantly after cell exposure to NiSO 4 and DNFB, although DNFB exhibited a stronger activity. There was no effect with DCNB. The epidermal cytokine granulocytemacrophage colony-stimulating factor (GM-CSF), also used in the experiments, slightly increased the expression of both CD40 and IL-12R and when tested together with the sensitizers the effect was partially additive. The results suggest that the sensitizers DNFB and NiSO 4 are directly involved on the changes of the surface markers CD40 and IL-12R in skin DCs, during the sensitization phase of CHS, and this effect may be enhanced by GM-CSF. In contrast, no effect was observed with DCNB.
INTRODUCTION
Contact hypersensitivity (CHS) is a common inflammatory skin disease that occurs as a consequence of increasing exposure to exogenous chemicals. It is a dendritic cell-dependent, T cell-derived and cytokine-mediated skin inflammation (Enk, 1997; Watanabe et al., 2002) . Langerhans cells (LCs) and keratinocytes are epidermal cells that produce, constitutively or upon exogenous stimulation, a wide range of cytokines (Kimber et al., 1995) . These cytokines interact with appropriate receptors expressed by LCs becoming crucial in the sensitization phase and in initiation of the CHS (Watanabe et al., 2002) .
LCs and other skin dendritic cells (DCs) are antigen presenting cells (APCs) that play an important role in determining the cutaneous response to small chemicals applied at the skin surface (Enk, 1997; Watanabe et al., 2002) . These cells capture the small molecular weight exogenous chemical (the hapten) by phagocytosis or by pynocytosis, process it into a small hapten-modified peptide and combine this allergen with a MHC molecule (Lipscomb and Masten, 2002) . At this stage skin DCs are very efficient in the uptake and processing of the antigens but poor stimulators of primary T cell responses and, in the skin they would not find naı¨ve T cells for priming. Therefore, they undergo maturation to become potent APCs and migrate to the skin draining lymph nodes searching the appropriate naı¨ve T cells for sensitization (Girolomoni et al., 1995; Pieri et al., 2001; Satthaporn and Eremin, 2001 ).
The migration and maturation process of skin DCs involves profound changes on the molecules that are expressed at their cell surface (Banchereau and Steinman, 1998) , namely MHC class II (Herouet et al., 2000) and costimulatory molecules (Coutant KD et al., 1999; Tuschl and Kovac, 2001) , and on those secreted to the extracellular milieu, including cytokines (Pichowski et al., 2000; De Smedt et al., 2001 ) and metalloproteinases (Ratzinger et al., 2002) .
In vitro studies, using whole human skin models, cultures of DCs derived from circulating CD34+ cells or immortalized animal skin dendritic cells (Girolomoni et In this work, using a mouse fetal skin dendritic cell line (FSDC), we studied the changes in the expression of membrane-associated receptors induced by chemicals with different skin sensitizing properties, alone or in the presence of GM-CSF. GM-CSF is one of the epidermal cytokines produced by keratinocytes after epidermal application of skin sensitizers, being responsible for DC maturation (Kimber et al., 1995; Pieri et al., 2001 ). The present work showed that nickel sulfate (NiSO 4 ), the most prevalent allergen in the human population, and DNFB, a potent experimental sensitizer, upregulated DC expression of the CD40 protein and of the IL-12 receptor (IL-12R). In contrast 2,4-dichloronitrobenzene (DCNB), an analogous of DNFB which is considered a non-sensitizer (Becker et al., 1994) , did not exhibit these effects. The epidermal cytokine GM-CSF, which induces the maturation of FSDC (Kimber et al., 1995; Jonuleit et al., 1996), also slightly increased CD40 and IL-12R expression, and this effect was additive with the response to the sensitizers.
MATERIALS AND METHODS

Materials
DNFB was purchased from Sigma-Aldrich Quı´mica (Madrid, Spain). DCNB and NiSO 4 were from Sigma Chemical Co (St. Louis, MO, USA). The mouse recombinant GM-CSF was from R & D systems (Minneapolis, MN, USA). The rabbit anti-mouse CD40 immunoglobulin and the rabbit anti-human antibody to IL-12 receptor beta 1 subunit (IL-12Rb1) were obtained from Santa Cruz Biotechnology (Santa Cruz, CA). The mouse monoclonal antibody against actin and the protease inhibitor cocktail were from Roche (Carnaxide, Portugal). Fetal calf serum was from Biochrom KG (Berlin, Germany) and trypsin from Invitrogen (Paisley, UK). The fluorescein isothiocyanate (FITC)-conjugated swine anti-rabbit immunoglobulin and the swine serum were from DAKO (Copenhagen, Denmark). The mounting medium for fluorescence, Vectashield, was obtained from Vector Laboratories, Inc. (Burlingame, CA, U.S.A.). The ECL western blotting analysis system, the horseradish peroxidase-conjugated donkey anti-rabbit immunoglobulin and the X-ray films were from Amersham Biosciences (Carnaxide, Portugal). The horseradish peroxidaseconjugated goat anti-mouse immunoglobulin was from Pierce (Illinois, USA). TritonÒ X 100 and paraformaldehyde were from Merck (Lisboa, Portugal). All other reagents were from Sigma Chemical Co (St. Louis, MO, USA).
Cell culture
The fetal mouse skin dendritic cell line FSDC, kindly supplied by Dr. G. Girolomoni (Laboratory of Immunology, Instituto Dermopatico dell'Imacolata, IRCCS, Rome, Italy), is a skin dendritic cell precursor with antigen presenting capacity (Girolomoni et al., 1995) . The cells were cultured in endotoxin free Iscove's Modified Dulbecco's Medium (IMDM), supplemented with 10% (v/v) fetal calf serum, 1% (w/v) glutamine, 3.02 g/l sodium bicarbonate, 100 lg/ml streptomycin and 100 U/ml penicillin. For western blot analysis, FSDC were plated at 2 · 10 6 cells/well, in six-well culture plates, whereas for immunofluorescence analysis, FSDC cells were grown on a Lab-Tek chamber slide with cover (0.2 · 10 6 cells/slide). The effect of DNFB and NiSO 4 on the expression of CD40 and IL-12R in FSDC was determined by western blot and immunocytochemistry, after incubating the cells with the compounds for 24 hr. The concentrations of DNFB (1 lg/ml) and NiSO 4 (50 lg/ml) used were those that produced maximal effect and no toxicity (data not shown), as evaluated by the reduction of the tetrazolium bromide salt, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) (Mosmann, 1983) .
NiSO 4 was dissolved in culture medium. DNFB and DCNB were dissolved in DMSO in a stock solution (10 mg/ml). Before incubation of the cells with these compounds (DNFB and DCNB) the stock solution was diluted in sterile PBS (10 ·) and the final concentrations of DNFB and DCNB were further diluted in the culture medium containing the FSDC cells (1000 ·). Therefore, the concentration of DMSO incubated with cells never exceeded 0.01%. Under these experimental conditions the assay of cellular MTT reduction (a viability assay) in the presence of this concentration of DMSO revealed no toxic effect and this concentration of DMSO alone was without effect on CD40 and IL-12R expression (data not shown).
Western blot analysis
Total cell lysates were obtained after harvesting the cells in a sonication buffer containing 0.32 M sucrose, 10 mM Tris-HCl (pH 7.5), 1 mM ethylene-diaminetetraacetic acid, 1 mM dithiothreitol, 0.1 mM phenylmethylsulfonylfluoride and the protease inhibitor cocktail. Then, the lysates were incubated on ice for 30 min and sonicated to disrupt the cells. Protein concentration was determined using the bicinchoninic acid method.
In brief, protein samples were denatured and separated on a 10% (v/v) SDS-PAGE, and transferred to a PVDF membrane. The membrane was blocked with 5% (w/v) dry milk in Tris-buffered saline with 0.1% (v/v) Tween 20, for 1 hr. The levels of CD40 and IL-12Rb1 proteins were detected using a rabbit anti-mouse CD40 (1:500) and a rabbit anti-human IL-12Rb1 (1:500) antibody, for 1 hr, followed by incubation with a horseradish peroxidase-conjugated donkey anti-rabbit antibody (1:5000). The immunocomplexes were visualized by the ECL chemiluminescence method. To demonstrate equivalent protein loading the membranes were stripped and reprobed with an anti-actin antibody (1:10000), followed by incubation with a horseradish peroxidase-conjugated goat anti-mouse immunoglobulin (1:25000).
Immunofluorescence microscopy (immunocytochemistry)
After incubation in the absence or in the presence of the appropriate stimuli, as indicated in Figs. 2c and 3c, the cells were washed with PBS and fixed with PBS containing 4% (w/v) sucrose and 4% (w/v) paraformaldehyde, for 15 min. FSDC were then permeabilized in PBS containing 1% (v/v) TritonÒ X 100, for 10 min. Non-specific binding was blocked by incubation of the cells with PBS supplemented with normal swine serum (1:20) and 0.5% (w/v) BSA-PBS, for 45 min, at room temperature. Cells were then incubated with a rabbit anti-mouse CD40 immunoglobulin (1:50) or with a rabbit anti-human IL-12Rb1 antibody (1:50), for 90 min at room temperature. After rinsing with PBS, the cells were incubated with FITC-conjugated swine anti-rabbit immunoglobulin (1:40) in 0.5% BSA-PBS, for 45 min. The cells were rinsed again and mounted with the mounting medium for fluorescence, Vectashield. Cells labeled with FITC-anti CD40 or with FITC-anti IL-12Rb1 antibodies were photographed on a Zeiss Axiovert 200 microscope. Control experiments consisted of processing the same preparations as described, except for the omission of the primary antibody, and resulted in no specific staining.
Data analysis
Results are presented as mean ± SEM of the indicated number of experiments. Mean values were compared using one-way ANOVA and the Bonferroni's multiple comparison test. The significance level was *p < 0.05, **p < 0.01 and ***p < 0.001.
RESULTS
Effect of NiSO 4 , DNFB and DCNB on CD40 expression in FSDC
Stimulation of the cells with NiSO 4 (50 lg/ml) or DNFB (1 lg/ml), for 24 hr, increased significantly the expression of CD40, by 32 and 50%, respectively (Fig. 1a,  lanes 3 and 4) as demonstrated by western blot. In order to determine how FSDC maturation affects the expression of CD40 induced by sensitizers, the cells were preincubated with GM-CSF (100ng/ml), for 24 hr, before stimulation with NiSO 4 Fig. 1a and b , incubation of FSDC cells with GM-CSF, for 48 hr, increased the expression of CD40 by 23%, but this effect did not reach statistical significance (Fig. 1a, lane 2) . However, when FSDC cells were incubated with NiSO 4 (50 lg/ml) or DNFB (1 lg/ml), for 24 hr, together with GM-CSF, after a 24 hr pre-incubation with the cytokine, the increase in the expression of CD40 was slightly higher but not statistically different from that observed in the presence of the sensitizers alone (58 and 70%, respectively) (Fig. 1a, lanes 5 and 6) . Interestingly, the small effect of GM-CSF on the expression of CD40 appears to be additive with the response to the sensitizers. When the cells were incubated with the non-sensitizer DCNB the observed effect was not different from the control (Fig. 1a, lane 7) .
In Fig. 1c , immunofluorescence microscopy experiments performed under the same experimental conditions confirmed all these results, demonstrating an upregulation of CD40 expression induced by the sensitizers NiSO 4 and DNFB, and a slightly higher increase in the expression of the protein in cells pre-incubated with GM-CSF. Immunofluorescence also confirmed that the non-sensitizer DCNB had no significant effect on this model.
Effect of NiSO 4 , DNFB and DCNB on IL-12R expression in FSDC
The effect of NiSO 4 , DNFB and DCNB on the expression of IL-12R in FSDC cells is summarized in Fig. 2a and b . In FSDC cells incubated with NiSO 4 (50 lg/ml) or with DNFB (1 lg/ml), for 24 hr, the expression of IL-12R was increased by 45 and 72%, respectively, when compared with control cells, i.e., cells incubated with culture medium (Fig. 2a, lanes 1, 4 and 5) . DCNB had no effect on this model (Fig. 2a, lane  7) . In order to determine how FSDC maturation affects the expression of the IL-12R induced by sensitizers, the cells were pre-incubated with GM-CSF (100 ng/ml), for 24 hr, before stimulation for an additional 24 hr with NiSO 4 or DNFB, together with the cytokine. When the cells were incubated only with GM-CSF, for 48 hr, we observed a non-statistically significant increase of IL-12R expression of 23% (Fig 2a,  lane 2) . When FSDC cells were incubated with the sensitizers NiSO 4 (50 lg/ml) or DNFB (1 lg/ml), for 24 hr, together with GM-CSF, after a 24 hr pre-incubation with the cytokine, the increase in IL-12R expression (66 and 90%, respectively) was higher but not statistically different from that observed in cells stimulated only by the sensitizers (Fig. 2a, lanes 3 and 6) . As observed for the expression of CD40, the small effect of GM-CSF on IL-12R expression was additive with the response to the sensitizers. When the cells were incubated with the non-sensitizer DCNB the observed effect was not different from the control (Fig. 2a, lane 7) .
In Fig. 2c , immunofluorescence microscopy confirmed all of these results, demonstrating an upregulation of IL-12R expression induced by the sensitizers NiSO 4 and DNFB in cells pre-incubated or not with GM-CSF. The immunofluorescence also confirmed that the non-sensitizer DCNB did not affect the expression of the IL-12R.
DISCUSSION
FSDC is a fetal mouse skin derived dendritic cell line, which represents a model of a skin DC precursor. These cells are sensitive to and require cytokine activation to become functionally efficient APCs (Girolomoni et al., 1995) . We have previously shown that FSDC are sensitive to the epidermal cytokine GM-CSF (Cruz et al., 2001; Vital et al., 2003) , which is involved on DC differentiation and maturation (Kimber et al., 1995; Jonuleit et al., 1996; Banchereau and Steinman, 1998) .
In this work, we studied the effect of two strong contact sensitizers, DNFB and NiSO 4 , on the expression of two membrane-associated receptors, CD40 and IL-12R, in FSDC. The results show that both skin sensitizers upregulated the expression of the two cell surface molecules, CD40 and IL-12R, whereas the non-sensitizer DCNB had no significant effect (Figs. 1 and 2) . In another set of experiments we tested the effect of pre-incubating FSDC with GM-CSF, which induces FSDC maturation sensitizers. The results show that GM-CSF alone slightly increased CD40 and IL-12R expression, and this effect was additive with the result of cell stimulation only with the allergens (Figs. 1 and 2) .
The upregulation in the expression of CD40 observed here (Fig. 1 ) is in agreement with the results obtained in other DCs (Coutant et al., 1999) . CD40 is a membrane-associated receptor belonging to the tumor necrosis factor-receptor (TNF-R) family that is expressed broadly, including in DCs (van Kooten and Banchereau, 2000) . CD40 interacts with the CD40 ligand (CD40L) on naı¨ve T cells in a process important for initiating primary immune responses . CD40 activation by CD40L is critical for maintaining DC viability, to promote their maturation through the upregulation of costimulatory molecules and to control their migration to the draining lymph nodes ( . Therefore, CD40 could be regarded as a surface marker of DC activation. In the present work we also found that DNFB induced a higher increase in CD40 expression than NiSO 4 ( Fig. 1) , which is in agreement with the in vitro and in vivo stronger activity of this skin sensitizer (Yokozeki et al., 1995) .
FSDC were cultured with GM-CSF in the absence or in the presence of the contact sensitizers, in order to mimic the in vivo events. During CHS, epidermal keratinocytes provide a wide range of cytokines that influence the differentiation of cells of the dendritic lineage, in particular Langerhans cells. GM-CSF is one of these cytokines, relevant for the maintenance of the differentiated state of LCs within epidermis (Pieri et al., 2001) . Also, a variety of environmental stimuli, including epicutaneous contact with the skin sensitizers used in the present work, induce epidermal keratinocytes to release inflammatory and chemotactic cytokines and growth promoting cytokines, namely GM-CSF (Corsini and Galli, 1998) . In fact, our results show that GM-CSF alone slightly increased CD40 expression, a marker of DC maturation, which is in agreement with a previous report showing that GM-CSF slightly upregulated CD40 expression in purified LCs (Salgado et al., 1999) . The slightly higher CD40 upregulation in the presence of GM-CSF together with sensitizers indicate that the effect of these two stimuli was additive . However, the effect of skin sensitizers on IL-12R expression had never been addressed before.
Previous reports have shown that contact sensitizers like DNCB, which has a similar sensitizing potential as DNFB, can induce IL-12p40 subunit production by some APCs (Warbrick et al., 1999) . Therefore, DC upregulation of IL-12R induced by the sensitizers could be fundamental for the engagement of IL-12 produced by the DC itself or by other cells in the vicinity, thus promoting IL-12 signaling and functional DC activation. Accordingly, studies concerning the regulation of IL-12R have shown that an increase in IL-12 production and release is sufficient to induce expression of the two subunits of IL-12R, beta 1 and beta 2, by an autocrine mechanism in T cells (Rogge et In summary, we observed that the two skin contact sensitizers, DNFB and NiSO 4 , increased FSDC expression of the two membrane-associated receptors, CD40 and IL-12R, whereas the non-sensitizer DCNB had no significant effect as expected. GM-CSF also increased in a small extent the expression of both proteins, and this effect was additive with the effect of the allergens. These results suggest that these skin contact sensitizers induced early specific phenotype changes that may represent an early-activation state of the DCs, which could be responsible for the initiation of the sensitization phase of CHS in vivo. In addition, these results also suggest that the epidermal cytokine GM-CSF is involved on these changes. Moreover, we interestingly observed that the higher expression of CD40 and IL-12R was obtained with the stronger sensitizer DNFB, whereas NiSO 4 induced a lower expression of those proteins. Our results suggest that upregulation of CD40 and IL-12R expression could also be a promising readout in prescreening for strong and moderate contact sensitizers and could help to develop an in vitro assay to reduce the number of experimental animals used for ascertaining the sensitizing potential of environmental chemicals.
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